Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine

Publisher： MDPI

E-ISSN： 2075-4426|8|1|8-8

ISSN： 2075-4426

Source： Journal of Personalized Medicine, Vol.8, Iss.1, 2018-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationship of CYP2C19*2 and CYP2C19*3 Gene Polymorphism with Clopidogrel Response Variability and Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention

Pharmacology, Vol. 91, Iss. 3-4, 2013-02 ,pp. : 165-172

Karger

Access to resources Recommend Favorite

Time-dependent Inhibition of CYP2C8 and CYP2C19 by Hedera helix Extracts, A Traditional Respiratory Herbal Medicine

By Rehman Shaheed Ur Kim In Sook Choi Min Sun Kim Seung Hyun Zhang Yonghui Yoo Hye Hyun

Molecules, Vol. 22, Iss. 7, 2017-07 ,pp. : 1241-1241

MDPI

Access to resources Recommend Favorite

The CYP2C19 Enzyme Polymorphism

Pharmacology, Vol. 61, Iss. 3, 2000-09 ,pp. : 174-183

Karger

Access to resources Recommend Favorite

The Effects of H₂S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat

By Wang Xianqin Han Anyue Wen Congcong Chen Mengchun Chen Xinxin Yang Xuezhi Ma Jianshe Lin Guanyang

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 24055-24063

MDPI

Access to resources Recommend Favorite

Effects of CYP2C19 Variants on Fluoxetine Metabolism in vitro

Pharmacology, Vol. 100, Iss. 1-2, 2017-05 ,pp. : 91-97

Karger

Access to resources Recommend Favorite